Evidence map›Paper›PMID 37753094›Full record

ArticleFrontiers in immunology2023

A clash on the Toll pathway: competitive action between pesticides and zymosan A on components of innate immunity in

Dani Sukkar, Ali Kanso, Philippe Laval-Gilly, Jairo Falla-Angel

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Clodronate liposomes untangle the role of hemocytes inbioRxiv : the preprint server for biology · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Dani SukkarLaboratoire Sols et Environnement, Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (INRAE), Université de Lorraine, Nancy, France.
Ali KansoBiology Department, Faculty of Sciences I, Lebanese University, Hadath, Lebanon.
Philippe Laval-GillyLaboratoire Sols et Environnement, Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (INRAE), Université de Lorraine, Nancy, France.
Jairo Falla-AngelLaboratoire Sols et Environnement, Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (INRAE), Université de Lorraine, Nancy, France.
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement · FRLebanese University · LB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The immune system of honeybees includes multiple pathways that may be affected by pesticide exposure decreasing the immune competencies of bees and increasing their susceptibility to diseases like the fungal Nosema spp. infection, which is detected in collapsed colonies. Methods: To better understand the effect of the co-presence of multiple pesticides that interact with bees like imidacloprid and amitraz, we evaluated the expression of immune-related genes in honeybee hemocytes. Results: Imidacloprid, amitraz, and the immune activator, zymosan A, mainly affect the gene expression in the Toll pathway. Discussion: Imidacloprid, amitraz, and zymosan A have a synergistic or an antagonistic relationship on gene expression depending on the level of immune signaling. The presence of multiple risk factors like pesticides and pathogens requires the assessment of their complex interaction, which has differential effects on the innate immunity of honeybees as seen in this study.

Indexed as

Immunity, InnatePesticidesToll-Like ReceptorsZymosanAnimalsBeesGene Expression RegulationHemocytesInsect ProteinsNeonicotinoidsNitro CompoundsNosemaSignal TransductionToluidinesimidaclopridInsect ProteinsNeonicotinoidsNitro CompoundsPesticidesToll-Like ReceptorsToluidinesZymosanamitrazhoneybeesimidaclopridimmune genesimmune modulationToll pathwayβ-glucan

Identifiers

PMID37753094
PMCPMC10518393
OpenAlexW4386605902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.